AP
MDT icon

Arlington Partners’s Medtronic MDT Stock Holding History

Arlington Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Buy
3,445
+749
+28% +$60.4K 0.49% 26
2026
Q1 		$234K Buy
+2,696
New +$258K 0.47% 56
2025
Q4 		– Sell
-54,158
Closed -$5.16M – 34
2025
Q3 		$5.16M Buy
54,158
+2,296
+4% +$211K 1.78% 16
2025
Q2 		$4.52M Buy
51,862
+2,317
+5% +$196K 1.67% 23
2025
Q1 		$4.45M Buy
49,545
+10,586
+27% +$947K 1.75% 23
2024
Q4 		$3.11M Sell
38,959
-10,232
-21% -$886K 1.21% 48
2024
Q3 		$4.43M Buy
49,191
+9,643
+24% +$811K 1.73% 16
2024
Q2 		$3.11M Buy
39,548
+4,430
+13% +$363K 1.55% 47
2024
Q1 		$3.06M Buy
35,118
+27,472
+359% +$2.34M 1.56% 37
2023
Q4 		$630K Buy
+7,646
New +$583K 0.18% 68
2023
Q2 		– Sell
-38,407
Closed -$3.1M – 624
2023
Q1 		$3.1M Buy
38,407
+5,152
+15% +$420K 0.44% 19
2022
Q4 		$2.58M Buy
33,255
+549
+2% +$44.5K 0.41% 25
2022
Q3 		$2.64M Buy
32,706
+4,455
+16% +$400K 1.06% 21
2022
Q2 		$2.54M Buy
28,251
+1,882
+7% +$191K 0.84% 23
2022
Q1 		$2.93M Buy
26,369
+6,014
+30% +$635K 0.83% 22
2021
Q4 		$2.11M Sell
20,355
-1,078
-5% -$125K 0.57% 41
2021
Q3 		$2.69M Buy
21,433
+3,041
+17% +$394K 0.77% 30
2021
Q2 		$2.28M Buy
18,392
+235
+1% +$29.5K 0.79% 29
2021
Q1 		$2.15M Buy
18,157
+1,389
+8% +$163K 0.79% 27
2020
Q4 		$1.96M Buy
16,768
+15
+0.1% +$1.65K 0.9% 23
2020
Q3 		$1.74M Sell
16,753
-31
-0.2% -$3.11K 0.95% 26
2020
Q2 		$1.54M Buy
16,784
+1,769
+12% +$170K 0.86% 29
2020
Q1 		$1.35M Buy
15,015
+12,066
+409% +$1.28M 0.7% 27
2019
Q4 		$335K Buy
2,949
+235
+9% +$25.8K 0.21% 42
2019
Q3 		$295K Sell
2,714
-11,771
-81% -$1.23M 0.19% 40
2019
Q2 		$1.41M Buy
+14,485
New +$1.32M 0.63% 36
2018
Q3 		– Sell
-10,219
Closed -$875K – 222
2018
Q2 		$875K Buy
+10,219
New +$854K 0.83% 28
2018
Q1 		– Sell
-10,044
Closed -$811K – 140
2017
Q4 		$811K Buy
+10,044
New +$804K 0.84% 32

Other funds holding MDT

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
MAA
Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Arlington Partners's MDT Position: Q2 2026 in Review

Arlington Partners increased its Medtronic (MDT) stake by 28% in Q2 2026, buying an estimated $60.4K and bringing the position to 3,445 shares worth $270K. The position accounts for 0.49% of the portfolio, ranked #26.

Arlington Partners first reported a position in MDT in Q4 2017 and has held it in 28 quarters since. The position peaked at $5.16M in Q3 2025. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Arlington Partners held 3,445 shares of Medtronic worth $270K as of Q2 2026.
  • Arlington Partners bought 749 Medtronic shares in Q2 2026, an estimated $60.4K.
  • Medtronic made up 0.49% of Arlington Partners's portfolio in Q2 2026, its #26 holding.
  • Arlington Partners first reported a position in Medtronic in Q4 2017 and has held it in 28 quarters since.
  • Arlington Partners's Medtronic position peaked at $5.16M in Q3 2025.
  • 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Arlington Partners's 13F filing for Q2 2026, filed 7 Jul 2026.